Literature DB >> 12413511

Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.

A P Coletta1, A A Louis, A L Clark, N Nikitin, J G F Cleland.   

Abstract

This article continues a series of reports on research developments related to the field of heart failure. Reports of presentations made at the Hot Line sessions of the European Society of Cardiology XXIV Congress held in Berlin, Germany, between 31 August and 4 September 2002 are included. Summaries of the results of the following trials are presented: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. Copyright 2002 European Society of Cardiology

Entities:  

Mesh：

Year:  2002        PMID： 12413511     DOI： 10.1016/s1388-9842(02)00176-9

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


  4 in total

Review 1.  Systematic review of multidisciplinary interventions in heart failure.

Authors:  R Holland; J Battersby; I Harvey; E Lenaghan; J Smith; L Hay
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 2.  Clinical service organisation for heart failure.

Authors:  S Taylor; J Bestall; S Cotter; M Falshaw; S Hood; S Parsons; L Wood; M Underwood
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 3.  Cardiac resynchronization therapy--how big of a miracle?

Authors:  Philip B Adamson
Journal:  Curr Heart Fail Rep       Date:  2004 Apr-May

4.  Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study.

Authors:  Idris Guessous; William McClellan; Suma Vupputuri; Haimanot Wasse
Journal:  BMC Nephrol       Date:  2009-09-16       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.